Intestinal Protein Loss Mechanisms in Gastrointestinal Disorders

Intestinal protein loss encompasses a spectrum of mechanisms by which plasma proteins escape into the gastrointestinal lumen, leading to hypoalbuminaemia, oedema and immunodeficiency. Three principal pathways have been identified: disruption of the epithelial barrier in inflammatory conditions, dilation and rupture of lymphatic channels in lymphangiectasia, and elevated mucosal permeability secondary to portal hypertension or vascular injury. Inflammatory bowel diseases and infectious enteropathies drive exudative protein loss through cytokine-mediated damage to enterocytes and capillaries. Primary and secondary lymphangiectasia result from congenital or acquired obstruction of intestinal lymphatics, promoting leakage of chyle rich in albumin and immunoglobulins. In cirrhosis and congestive states, raised lymphatic pressure contributes to lymph leakage and worsened ascites. Clinically, protein loss manifests as peripheral oedema, diarrhoea and nutrient deficiencies. Diagnosis relies on a combination of endoscopic imaging, lymphatic studies, stool protein markers and histology. Management is tailored to the underlying mechanism and ranges from dietary interventions, notably low-fat regimens with medium-chain triglycerides, to medical therapies targeting lymphatic flow or inflammation, and surgical or interventional radiology procedures in refractory cases. Understanding these pathways underpins improved outcomes and informs development of targeted interventions worldwide.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Intestinal Protein Loss Mechanisms in Gastrointestinal Disorders publication trend

The graph below shows the total number of articles in intestinal protein loss mechanisms in gastrointestinal disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Protein-losing enteropathy: Excessive loss of plasma proteins into the gastrointestinal tract, resulting in hypoalbuminaemia and related symptoms.

Intestinal lymphangiectasia: Pathological dilation and rupture of intestinal lymphatic vessels causing lymph leakage and protein loss.

Lacteals: Small lymphatic capillaries within intestinal villi responsible for absorption and transport of dietary fats.

α1-Antitrypsin clearance: A quantitative stool test used to assess the degree of enteric protein loss.

References

1. Small intestinal mucosal abnormalities using video capsule endoscopy in intestinal lymphangiectasia. Orphanet Journal of Rare Diseases (2023).
2. Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature. BMC Pediatrics (2021).
3. First case report of intestinal lymphangiectasia with refractory bleeding from the duodenum, successfully treated by intra-abdominal lymphaticovenous anastomosis with venous ligation. Clinical Journal of Gastroenterology (2024).